Compounded tirzepatide
Does insurance cover compounded tirzepatide?
Quick answer
Not the compounded vial. A plan that covers tirzepatide covers an approved product: Zepbound for weight management or Mounjaro for type 2 diabetes, depending on your indication and formulary. Compounded tirzepatide is a cash market, and it says so: 43 of the 384 sellers on this index advertise “no insurance required” as a reason to buy.
If your plan declines Zepbound, compare the equivalent calendar-month cost of self-pay vials: $325.03 at the starting strength and $488.09 from 7.5 mg up under the qualifying refill program (calendar-month equivalents).
Zepbound vials or KwikPen: $299 per 28 days at 2.5 mg, $399 at 5 mg (a maintenance dose), and $449 at 7.5–15 mg with the Self Pay Journey Program. The $449 rate requires a first fill or refill within 45 days; otherwise regular higher-dose fills cost $499 at 7.5 mg or $699 at 10–15 mg. Eligibility and other terms apply. All comparison amounts use 30.4375 days: each 28-day brand fill × 30.4375 ÷ 28. These are cost equivalents, not checkout charges. Manufacturer terms (checked October 2026).
What the sellers themselves say
This is not a claim about your plan. It is a count of what 68 sellers wrote on their own pages, read on a recorded date. Three examples, quoted exactly:
- “We do not accept insurance. Luma Health Co. operates on a direct-to-patient model.”
- “At this time, we do not work with medical insurance.” — Telehealth Weight Solutions
- “No insurance needed” — printed beside the price, on seller after seller
That last one is the point. A cash price is not something these sellers apologize for; it is the pitch. Skipping insurance is how a telehealth seller can put a number on a landing page at all — and it is why this index can compute one.
Without coverage, the cash price is the whole cost. Among the sellers we work with, the SnagRx review records $162 a calendar month at every dose, the Shed review $299 a calendar month at the starting dose and the SkinnyRx review $299 a calendar month at every dose. We may earn a commission from these sellers, and the full index orders every seller by price alone.
Brand-name and compounded coverage differ
Measured publishes two lines of business side by side. Its compounded plan is all-in cash and its own page says “No insurance required”. Its brand-name plan — the same company, the same checkout — reads “Medication covered by insurance or cash pay”.
Insurance attaches to the approved product. It does not follow the molecule into a compounded vial. You can see the split inside a single seller’s pricing.
The one insurance-first practice we have checked makes the same point from the other side: it is a primary-care group where medication runs through your plan, and it publishes no medication price at all — because there isn’t one to publish. What you pay depends on your formulary, not on the seller.
If you do have coverage, price Zepbound or Mounjaro
This is the useful version of the answer. If your plan covers tirzepatide for your indication, the thing to price is Zepbound or Mounjaro, not a compounded vial — and your copay may well beat every number on this site.
If it does not, the comparison that matters is against Eli Lilly’s own self-pay vial rather than against a copay you cannot get. Zepbound’s direct price is equivalent to $325.03 per calendar month at 2.5 mg and $488.09 at 7.5–15 mg with qualifying refills, against a compounded median of $266.21. The dose-by-dose crossover is worked out on compounded vs Zepbound.
Medicare: check the branded option first
Eligible Part D enrollees may access Zepbound KwikPen through the Medicare GLP-1 Bridge for $50 monthly. The program runs July 1, 2026–December 31, 2027 and requires prescriber prior authorization under clinical eligibility criteria. It excludes Zepbound single-dose vials and pens; it does not cover compounded tirzepatide. Ordinary Part D coverage for qualifying indications is a separate pathway.
Checked October 17, 2026: CMS eligibility and formulations; CMS program cost. Ask your prescriber which pathway applies before choosing a cash subscription.
HSA and FSA are a different question, and often yes
20 sellers in this index advertise that they are HSA or FSA eligible. That is not insurance — nobody is adjudicating a claim — but it does mean many readers can pay with pre-tax dollars, which is a real discount on a cash price.
Eligibility depends on your own plan administrator and on having a prescription, so check with them rather than with the seller. What the seller can tell you is whether it will accept the card. The guide to separate fees shows what to look for beyond the medication charge. Ask the account administrator which charges qualify.
Nothing here is advice about your coverage, and nothing is a recommendation to start, stop or switch a medication. See the medical disclaimer.